XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis

Guobing Wang; Yunyue Li; Rui Pan; Xisheng Yin; Congchao Jia; Yuchen She; Luling Huang; Guanhu Yang; Hao Chi; Gang Tian

doi:doi:10.18632/aging.205426

← Back

Research Paper Volume 16, Issue 1 pp 872—910

XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis

Figure 9. The relationship between XRCC1 expression and pan-cancer immune subtypes. (A) in BLCA, (B) in BRCA, (C) in COAD, (D) in ESCA, (E) in HNSC, (F) in KIRC, (G) in LGG, (H) in LIHC, (I) in LUAD, (J) in PAAD, (K) in PCPG, (L) in PRAD, (M) in SARC, (N) in STAD, (O) in TGCT, (P) in UCS.